View More Recent Stories
-
Royalty Pharma plc (RPRX) Declares $0.21 Quarterly Dividend; 3.1% Yield
-
TD Cowen Reiterates Buy Rating on Royalty Pharma (RPRX)
-
Goldman Sachs Reiterates Buy Rating on Royalty Pharma (RPRX)
-
Ascendis Pharma (ASND) and Royalty Pharma (RPRX) Enter $150M Royalty Funding Agreement
-
Royalty Pharma plc (RPRX) Declares $0.21 Quarterly Dividend; 3% Yield

